This week, global drugmakers Pfizer and BioNTech said their COVID-19 vaccine candidate is 95% effective, including in adults over 65 years of age. “The recent breakthroughs on COVID-19 vaccines offer a ray of hope. But that ray of hope needs to reach everyone,” Mr. Guterres said at a news conference on Friday. “This funding is critical for mass manufacturing, procurement and delivery of new COVID-19 vaccines and tools around the world. G20 countries have the resources.

Source: The Hindu November 21, 2020 07:14 UTC